AbbVie Inc (XSGO:ABBVCL)
CLP 171,590 (0%) Market Cap: 436.39 Tn Enterprise Value: 497.05 Tn PE Ratio: 72.63 PB Ratio: 0 GF Score: 76/100

AbbVie Inc. at Morgan Stanley Global Healthcare Conference Transcript

Sep 15, 2026 / 02:00PM GMT
Terence Flynn
Morgan Stanley - Analyst

All right. Great. Thanks for joining us, everybody. I'm Terence Flynn, Morgan Stanley's US biopharma analyst. Very pleased to be hosting AbbVie.

For important disclosures, please see Morgan Stanley's research disclosure website at www.morganstanley.com/researchdisclosures. If you have any questions, please reach out to your Morgan Stanley sales representative.

As I mentioned, very pleased to be hosting AbbVie this morning. We have Rob Michael, the company's Chairman of the Board and CEO. We have Jeff Stewart, the company's EVP, Chief Commercial Officer; and Roopal Thakkar, the company's Head of R&D and Chief Scientific Officer. Thank you all three of you for joining me today. Really appreciate it.

Robert Michael
AbbVie Inc. - Chairman of the Board & Chief Executive Office

Great to be here.

Questions & Answers

Terence Flynn
Morgan Stanley - Analyst

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
7-Day Free Trial · Cancel Anytime
Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot